Frontlight ResearchEarly access
Trial site
Meenakshi Mission Hospital & Research Centre
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Heart failure1 trial
- Prostate cancer1 trial
- Phase
- Phase 32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Abbott Medical Devices1 trial
- Bayer1 trial
- Boehringer Ingelheim1 trial
- Karyopharm Therapeutics Inc1 trial
- Sun Pharma Advanced Research Company Limited1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026